Matches in SemOpenAlex for { <https://semopenalex.org/work/W2918371302> ?p ?o ?g. }
- W2918371302 endingPage "453" @default.
- W2918371302 startingPage "445" @default.
- W2918371302 abstract "To examine the prospective associations between exposure to perfluoroalkyl substances (PFASs) and longitudinal measurements of glucose metabolism in high-risk overweight and obese Hispanic children.Forty overweight and obese Hispanic children (8-14 years) from urban Los Angeles underwent clinical measures and 2-hour oral glucose tolerance tests (OGTT) at baseline and a follow-up visit (range: 1-3 years after enrollment). Baseline plasma perfluorooctanoic acid (PFOA), perfluorooctane sulfonate (PFOS), perfluorohexane sulfonic acid (PFHxS), and the plasma metabolome were measured by liquid-chromatography with high-resolution mass spectrometry. Multiple linear regression models were used to assess the association between baseline PFASs and changes in glucose homeostasis over follow-up. A metabolome-wide association study coupled with pathway enrichment analysis was performed to evaluate metabolic dysregulation associated with plasma PFASs concentrations. We performed a structural integrated analysis aiming to characterize the joint impact of all factors and to identify latent clusters of children with alterations in glucose homeostasis, based on their exposure and metabolomics profile.Each ln (ng/ml) increase in PFOA and PFHxS concentrations was associated with a 30.6 mg/dL (95% CI: 8.8-52.4) and 10.2 mg/dL (95% CI: 2.7-17.7) increase in 2-hour glucose levels, respectively. A ln (ng/ml) increase in PFHxS concentrations was also associated with 17.8 mg/dL increase in the glucose area under the curve (95% CI: 1.5-34.1). Pathway enrichment analysis showed significant alterations of lipids (e.g., glycosphingolipids, linoleic acid, and de novo lipogenesis), and amino acids (e.g., aspartate and asparagine, tyrosine, arginine and proline) in association to PFASs exposure. The integrated analysis identified a cluster of children with increased 2-h glucose levels over follow up, characterized by increased PFAS levels and altered metabolite patterns.This proof-of-concept analysis shows that higher PFAS exposure was associated with dysregulation of several lipid and amino acid pathways and longitudinal alterations in glucose homeostasis in Hispanic youth. Larger studies are needed to confirm these findings and fully elucidate the underlying biological mechanisms." @default.
- W2918371302 created "2019-03-11" @default.
- W2918371302 creator A5004117323 @default.
- W2918371302 creator A5007768066 @default.
- W2918371302 creator A5014339990 @default.
- W2918371302 creator A5015670492 @default.
- W2918371302 creator A5033141774 @default.
- W2918371302 creator A5033965963 @default.
- W2918371302 creator A5035904189 @default.
- W2918371302 creator A5045492508 @default.
- W2918371302 creator A5063846847 @default.
- W2918371302 creator A5075398471 @default.
- W2918371302 creator A5077022486 @default.
- W2918371302 creator A5079617140 @default.
- W2918371302 date "2019-05-01" @default.
- W2918371302 modified "2023-10-16" @default.
- W2918371302 title "Perfluoroalkyl substances, metabolomic profiling, and alterations in glucose homeostasis among overweight and obese Hispanic children: A proof-of-concept analysis" @default.
- W2918371302 cites W1456625250 @default.
- W2918371302 cites W1507720773 @default.
- W2918371302 cites W1518126931 @default.
- W2918371302 cites W1965561480 @default.
- W2918371302 cites W1966411110 @default.
- W2918371302 cites W1971182327 @default.
- W2918371302 cites W1980352649 @default.
- W2918371302 cites W1989326472 @default.
- W2918371302 cites W1989505831 @default.
- W2918371302 cites W1994861768 @default.
- W2918371302 cites W1995187187 @default.
- W2918371302 cites W2001077154 @default.
- W2918371302 cites W2003524154 @default.
- W2918371302 cites W2012660994 @default.
- W2918371302 cites W2014308840 @default.
- W2918371302 cites W2017771330 @default.
- W2918371302 cites W2025944550 @default.
- W2918371302 cites W2030560074 @default.
- W2918371302 cites W2031245034 @default.
- W2918371302 cites W2032047739 @default.
- W2918371302 cites W2034179283 @default.
- W2918371302 cites W2060552707 @default.
- W2918371302 cites W2086943531 @default.
- W2918371302 cites W2087299945 @default.
- W2918371302 cites W2097692855 @default.
- W2918371302 cites W2107665951 @default.
- W2918371302 cites W2115444723 @default.
- W2918371302 cites W2130319566 @default.
- W2918371302 cites W2158418727 @default.
- W2918371302 cites W2158958532 @default.
- W2918371302 cites W2160234571 @default.
- W2918371302 cites W2171589158 @default.
- W2918371302 cites W2199408341 @default.
- W2918371302 cites W2331936027 @default.
- W2918371302 cites W2335822531 @default.
- W2918371302 cites W2338627428 @default.
- W2918371302 cites W2502972890 @default.
- W2918371302 cites W2512299796 @default.
- W2918371302 cites W2535762306 @default.
- W2918371302 cites W2581442977 @default.
- W2918371302 cites W2625521340 @default.
- W2918371302 cites W2748764116 @default.
- W2918371302 cites W2756301349 @default.
- W2918371302 cites W2770741917 @default.
- W2918371302 cites W2781259227 @default.
- W2918371302 cites W2781288801 @default.
- W2918371302 cites W2793311982 @default.
- W2918371302 cites W2810160703 @default.
- W2918371302 cites W2891523709 @default.
- W2918371302 cites W3021248722 @default.
- W2918371302 cites W3024284236 @default.
- W2918371302 doi "https://doi.org/10.1016/j.envint.2019.02.047" @default.
- W2918371302 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6555482" @default.
- W2918371302 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30844580" @default.
- W2918371302 hasPublicationYear "2019" @default.
- W2918371302 type Work @default.
- W2918371302 sameAs 2918371302 @default.
- W2918371302 citedByCount "88" @default.
- W2918371302 countsByYear W29183713022019 @default.
- W2918371302 countsByYear W29183713022020 @default.
- W2918371302 countsByYear W29183713022021 @default.
- W2918371302 countsByYear W29183713022022 @default.
- W2918371302 countsByYear W29183713022023 @default.
- W2918371302 crossrefType "journal-article" @default.
- W2918371302 hasAuthorship W2918371302A5004117323 @default.
- W2918371302 hasAuthorship W2918371302A5007768066 @default.
- W2918371302 hasAuthorship W2918371302A5014339990 @default.
- W2918371302 hasAuthorship W2918371302A5015670492 @default.
- W2918371302 hasAuthorship W2918371302A5033141774 @default.
- W2918371302 hasAuthorship W2918371302A5033965963 @default.
- W2918371302 hasAuthorship W2918371302A5035904189 @default.
- W2918371302 hasAuthorship W2918371302A5045492508 @default.
- W2918371302 hasAuthorship W2918371302A5063846847 @default.
- W2918371302 hasAuthorship W2918371302A5075398471 @default.
- W2918371302 hasAuthorship W2918371302A5077022486 @default.
- W2918371302 hasAuthorship W2918371302A5079617140 @default.
- W2918371302 hasBestOaLocation W29183713021 @default.
- W2918371302 hasConcept C126322002 @default.
- W2918371302 hasConcept C134018914 @default.
- W2918371302 hasConcept C135870905 @default.
- W2918371302 hasConcept C141359234 @default.